secwatch.observer — SEC 8-K summary
======================================

Issuer:     Orthofix Medical Inc. (OFIX)
CIK:        0000884624
Form:       8-K
Filed at:   2026-06-11T11:01:40+00:00
Accession:  0001193125-26-266679
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Orthofix shareholders approve stock purchase plan share increase, elect directors
--------------------------------------------------------------------------------

- Shareholders approved Amendment No. 5 to Stock Purchase Plan, increasing authorized shares by 1.25M to 6.1M.
- All 10 director nominees elected; Burris (24.9M for, 5.2M against) and Paolucci (24.7M for, 5.4M against) had notable opposition.
- Advisory vote on executive compensation passed with 24.5M for, 5.6M against (81.4% approval).
- Ernst & Young ratified as independent auditor for FY 2026 with 33.3M votes in favor.
- Meeting quorum of 34.8M shares (86% of outstanding) present from 40.4M eligible shares.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/884624/000119312526266679/0001193125-26-266679-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/884624/000119312526266679/ofix-20260611.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-266679

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer